PIPER SANDLER COMPANIES (PIPR)
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PIPR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PIPR | Chairman | 64 | ["Former chief executive officer of Integra LifeSciences Corporation","10 years of experience in healthcare group at Goldman Sachs","Significant leadership experience","Deep experience and knowledge of healthcare and medical technology industries","Corporate governance","Financial, accounting, and risk management"] | ["Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IART | Executive Chairman of the Board of Directors | 50 | ["Formerly Chief Executive Officer until January 2012"] | [] | 2012 |
| ZBH | President and Chief Executive Officer | 46 | ["President and Chief Executive Officer of Integra LifeSciences Holdings Corporation since December 1997", "Supervised the medical technology practice at Goldman, Sachs & Co. as a managing director", "Ten years of experience at Goldman Sachs serving as a senior mergers and acquisitions advisor", "A.B. from the Woodrow Wilson School of Public and International Affairs at Princeton University", "M.B.A. and Ph.D. in Financial Economics from the University of Chicago, Graduate School of Business"] | ["Audit Committee", "Compensation and Management Development Committee (Chair)", "Corporate Governance Committee"] | 2008 |
Biography sourced from the proxy statement filing.
Stuart M. Essig Stuart M. Essig Age 64 Director since 2026 Piper Sandler Board Committees: Audit Principal Occupation: Mr. Essig was chief executive officer of Integra LifeSciences Corporation ( Integra ), a global medical technology company focused on innovative solutions for neurosurgery, tissue reconstruction, and advanced wound care, from 1997 to 2012. Since 2012, Mr. Essig has served as Integra s chairman, with service as executive chairman from 2024 to 2025. Before joining Integra, Mr. Essig was a managing director in the healthcare group at Goldman Sachs where he had 10 years of experience, serving as a senior mergers and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. Mr. Essig previously served on the boards of public companies Zimmer Holdings, St. Jude Medical, Owens & Minor, Orthofix, and SeaSpine. Qualifications: Mr. Essig possesses significant leadership experience as a former chief executive officer of a publicly traded company in the medical technology industry, and he brings valuable additional perspective from his service on the boards of other publicly traded companies. In addition, Mr. Essig has deep experience and knowledge of the healthcare and medical technology industries, which remain important sectors for our investment banking business. Highlighted Skills: Chief executive experience; investment banking or financial services industry experience; focus sector experience; corporate governance; financial, accounting, and risk management Other Current Public Company Directorships: Integra LifeSciences Corporation IDEXX Laboratories Other Previous Public Company Directorships Held within the Last Five Years: Orthofix Medical Inc. (2023 to 2024) SeaSpine Holdings Corporation (2014 to 2022)